Past Podcast Episodes

This special episode of RealTalk MS is sponsored by EMD Serono and MS in the 21st Century.

It's often said that MS doesn't just affect individuals, it affects families. And in this special episode of RealTalk MS, we're talking about family involvement in MS care with Dr. Alice Laroni and Trishna Bharadia.

Dr. Laroni is a neurologist with over 18 years of experience providing clinical care to MS patients and more than 13 years of experience in neuroimmunological research. Dr. Laroni is also an Assistant Professor of Neurology at the University of Genova.

Trishna Bharadia was diagnosed with MS in 2008, at the age of 28. She's a multi-award-winning health advocate and patient engagement advisor dedicated to raising awareness and finding solutions for people living with MS.

Both Trishna and Alice are active members of the MS in the 21st Century initiative. To learn more about MS in the 21st Century, please visit www.msinthe21stcentury.com.

 

If you're on an MS disease-modifying therapy and you're concerned about how effective your COVID-19 vaccination might be, or you aren't sure whether having MS qualifies you as being immunocompromised and cleared to receive a third dose of the COVID-19 vaccine, or you can't begin to figure out whether you qualify to receive a COVID-19 booster, then this podcast episode is for you.

Joining me to help us make sense of the flurry of recent announcements by the CDC and provide us with an update on his lab's work in looking at the immune response to COVID-19 vaccines among people living with MS who are on b-cell depleting therapies is the Chief of the Division of Multiple Sclerosis and Related Disorders and the Director of the Center for Neuroinflammation and Experimental Therapeutics at the University of Pennsylvania, Dr. Amit Bar-Or.

If you're living with MS in the U.K., we'll update you on your eligibility to receive a COVID-19 booster.

If you're living with MS in the European Union, we'll update you on the EMA's recommendation of Vumerity, an oral disease-modifying therapy for adults with relapsing-remitting MS.

We'll tell you about a drug that's been on the market for over a decade that's been shown to help manage overactive bladder among people living with MS.

Imagine having your phone send you an email or text letting you know that you're showing early signs of depression or cognitive dysfunction. We're talking about potentially game-changing technology that Apple is developing for the iPhone.

And we'll share the details of Episode 3 of The MS Caregiver Conundrum, which debuts Thursday, September 30th. Parenting includes its own set of caregiving responsibilities. Imagine adding the additional responsibilities that go with caring for a child with MS. In Episode 3, of The MS Caregiver Conundrum, we'll meet two remarkable moms, each of whom is not only a parent but a caregiver for a child living with pediatric MS.

We have a lot to talk about! Are you ready for RealTalk MS??!

Vaccine booster shots for people with MS in the U.K.  2:04

Vumerity for people with MS in the European Union?   3:48

Drug helps treat overactive bladder among people with MS  4:30

Apple is developing tech to identify depression and cognitive decline  6:11

Dr. Amit Bar-Or updates us on who gets a COVID-19 vaccine booster, who gets a 3rd dose, and all the rest  8:37

Share this episode  26:50

Catch The MS Caregiver Conundrum  27:10

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/213

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society COVID-19 Vaccine Guidance for People Living with MS
https://www.nationalmssociety.org/coronavirus-covid-19-information/multiple-sclerosis-and-coronavirus/covid-19-vaccine-guidance

National MS Society Additional (3rd) COVID-19 Vaccine Dose Guidance for People Living with MS
https://www.nationalmssociety.org/About-the-Society/News/Additional-COVID-19-Vaccine-Dose-(Booster)-and-MS

The MS Caregiver Conundrum Podcast
https://mscaregiverconundrum.com

STUDY: Efficacy of Fesoterodine Fumarate (8 mg) in Neurogenic Detrusor Overactivity Due to Spinal Cord Lesion or Multiple Sclerosis: A Prospective Study
https://onlinelibrary.wiley.com/doi/10.1002/nau.24790

Register for Big October 2021
https://cvent.me/0Kbo4e?rt=FHc6yg95SUyNOD1m6wi5iw&RefId=Attendee

Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

Download the RealTalk MS App for iOS
https://itunes.apple.com/us/app/realtalk-ms/id1436917200

Download the RealTalk MS App for Android
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk

Give RealTalk MS a rating and review
http://www.realtalkms.com/review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 213
Guest: Dr. Amit Bar-Or

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS